Xi’an Guokang Runjin Pharmaceutical Co.,Ltd was established on March of 2018.
With the Registered Capital CNY 50,000,000.00, it has taken over the Drugs Manufacture Licenses, technologist and other resources from Xi’an Reyphon Pharmaceutical Co.,Ltd. on June of 2019.
With the area of 66,000 Sq.meters, the company was located at Jinghe Industrial Park of Xi’an City,on the north bank of the Weihe River. It is around 20km to the central part of Xi’an City. By the integrity of GMP manufacture facilities, new products’ R&D, professional sales team , which lead us to be an high-tech enterprise for Steroids Drugs’ APIs in China.The company owns more than 80 employees and 20 people are Medium and senior professionals among them . The company has advanced production facilities and testing equipment, and with professional production lines of synthesis, refining and fermentation.
The key products certified by sGMP are as below:
Dexamthasone\Dexamethasone Sodium Phosphate\Dexamethasone Acetate\Betamethasone
The company’s above products have been Registered with India Drugs Registration Certificate(FORM 41) ,it laid us the foundation for entering India and international market.
more >
Year of Establishment:
2007
Total Assets(USD):
50,000,000 To 54,999,999
Total Number of Staff:
300 to 349
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Contract Manufacturing,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Main products are dominated by hormone products such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, betamethasone, which have passed the national GMP certificate.
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
50,000,000 To 54,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Main products are dominated by hormone products such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, betamethasone, which have passed the national GMP certificate.
Patents and Copyrights: